Biogen, Inc. (BIIB)
Biogen Market Cap: 24.97B for Jan. 14, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Eli Lilly & Co. | 957.23B |
| Stoke Therapeutics, Inc. | 1.744B |
| AbbVie, Inc. | 386.97B |
| Alnylam Pharmaceuticals, Inc. | 47.92B |
| Insmed, Inc. | 35.03B |
Market Cap Related Metrics
| PE Ratio | 15.52 |
| PS Ratio | 2.576 |
| Price to Book Value | 1.372 |
| Price to Free Cash Flow | 11.03 |
| Price | 170.23 |
| Earnings Yield | 6.44% |
| Operating PE Ratio | 10.23 |
| Normalized PE Ratio | 13.76 |